valu usd unless otherwis note
build bridg futur bridg
view report result slightli better
expect pharmaci segment post stronger perform
pbm lighter estim compani trim
guidanc increas spend wage invest ahead
aetna deal weigh share
result larg in-lin report result met recent
guidanc larg irrelev view report ep
ahead street pharmaci
segment result stronger model stronger rx
volum better margin began lap tricar loss pbm
report good sell season better expect revenu
margin expect
lower ebitda guidanc least
ebitda provid wage increas mani pharmaci employe
make invest ahead aetna transact
figur ramp compani would lap
start-up cost expens neither materi
complet unexpect lead creep fear invest
cost post aetna transact close could much higher
forecast mean year earn estim could prove
aggress note though revis pro forma
combin cvs-aet ebitda estim billion dollar
figur compani present believ captur today
announc risk increment invest and/or pbm client
trim estim model chang littl except
increas expens detail today result ep slide
ep estim
prior pro forma combin ep estim
expens higher blend tax rate
maintain outperform maintain outperform rate share
trim pt reflect new ep
estim expect aet transact complet use
pro forma ep estim would yield valuat
price prior trade day market close estimate unless otherwis note
bloomberg capit market estim upside/downside/target
price target share base appli
multipl ep estim use
multipl believ reflect share
histor trade last year
upsid scenario reflect pro forma earn
assum aet deal close upsid assum share
trade pro forma ep
downsid scenario unabl close aetna
acquisit amazon compani out-execut
compani lead potenti neg revis multipl
compress downsid scenario impli
ep estim
health provid wide array health care servic
long-term care pharmaci home infus servic
oper follow segment pharmaci servic
retail/long term corpor pharmaci servic
segment offer pharmaci benefit manag solut
well specialti drug manag retail long
term segment includ sell prescript drug
assort gener merchandis corpor segment
provid manag administr servic
believ inflect point corpor
life cycl pursu strategi vertic
integr announc acquisit aetna
import macro trend healthcar move
away fee servic transact model toward
coordin value-bas care deliveri view
collect asset could better util
coordin ownership believ
steerag capabl combin pbm could
drive volum cvss segment offset
risk busi loss relat acquisit
increas competit core pharmaci pbm
increas price pressur commerci payer
well underli drug environ
risk large-custom exclus defect either
retail pbm segment
act commentsnet lineebitda expens earli extinguish debt- incom tax tax contin disc op net incom attribut incom incom tax incom continu loss attribut non-controlling adj incom continu dilut adjust street share share pharmacy/ltcnet expect health corporationop margingross marginop margin healthcar technolog distribut
fy guid vs modelnet revenuegrowthopgrowthiniti guidanc revenuegrowthopgrowthiniti guidanc low-singl digitsour low-singl digitsour revenuegrowthopgrowthiniti guidanc singl digitsour singl digitsour servicesenterpris outlookretail/ltc exhibit cvs-aet pf model
includ revenu pbm attrit like conservativepf adj oper op margin lost synergies- none forma compani disclosur per recent guid tax new blend rate share comp interest lower tax rateaccret big upsidecombinedaetnacv health healthcar technolog distribut
price target share base appli multipl ep
estim use multipl believ reflect share
histor trade last year price target support outperform
risk rate price target
share see sever downsid risk rate price target risk includ
increas price competit walgreen retail pharmaci space well
reimburs pressur wors expect third-parti payer
also risk see increas competit relat pbm network strategi
could reduc script volum risk obtain approv
otherwis complet announc acquisit aetna
pbm side busi risk includ could lose busi
see meaning reduct margin relat serv client risk includ
regular competit could lose market share either optum express script
prime aetna acquisit also present risk could disrupt client
lastli see near-term busi risk remain chanc
amazon get aggress pharmaci space could weigh valuat
share near term
health corp engag provis health care servic oper
follow segment pharmaci servic retail long term corpor
pharmaci servic segment offer pharmaci benefit manag solut retail
long term segment includ sell prescript drug assort gener
merchandis corpor segment involv provid manag administr
servic compani headquart woonsocket ri
million
revenu
depreci amort
loss earli extinguish debt
incom incom tax provis
incom continu oper
loss discontinu oper net tax
net loss attribut non-controlling interest
net incom attribut health
earn particip secur
incom common sharehold
adjust incom incom tax provis
adjust incom continu oper
net loss attribut non-controlling interest
adjust incom continu oper attribut
